Change In Working Capital - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Theriva Biologics Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theriva Biologics Inc
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Theriva Biologics Inc
F:SFY
Change in Working Capital
$3.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
11%
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$49m
CAGR 3-Years
70%
CAGR 5-Years
49%
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
-$4.1B
CAGR 3-Years
-20%
CAGR 5-Years
-28%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$1.4B
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$721.7m
CAGR 3-Years
45%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Theriva Biologics Inc's Change in Working Capital?
Change in Working Capital
3.9m USD

Based on the financial report for Mar 31, 2024, Theriva Biologics Inc's Change in Working Capital amounts to 3.9m USD.

What is Theriva Biologics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
11%

Back to Top